Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB/ SE0000872095 /
SOBI/S
|
6/9/2023 5:30:00 PM
|
Chg.
-0.80
|
Volume |
Bid5:30:00 PM |
Ask5:30:00 PM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
221.20SEK
|
-0.36%
|
111,401
Turnover: 13.26 mill. |
-Bid Size: - |
-Ask Size: - |
65.24 bill.SEK |
0.00% |
20.11 |
Fundamentals
| |
FY 2020 |
Growth (1Y) |
| Per Share |
|
| Earnings per Share: |
11.01 SEK |
-2.48% |
| EPS Diluted: |
10.90 SEK |
-2.85% |
| Revenues per Share: |
51.79 SEK |
6.38% |
| Book Value per Share: |
68.57 SEK |
18.54% |
| Cash Flow per Share: |
17.70 SEK |
42.50% |
| Dividend per Share: |
0.00 SEK |
- |
| Total |
in mill. |
|
| Revenues: |
15,261.00 SEK |
7.11% |
| Net Income: |
3,245.00 SEK |
-1.79% |
| Operating Cash Flow: |
5,214.00 SEK |
- |
| Cash and Cash Equivalents: |
404.00 SEK |
- |
Valuation Ratios
| |
Current |
Latest FY* |
| P/E Ratio: |
20.11 |
15.09 |
| P/S Ratio: |
4.27 |
3.21 |
| P/BV ratio: |
3.23 |
2.42 |
| P/CF Ratio: |
12.51 |
9.39 |
| PEG: |
-8.11 |
-6.08 |
| Earnings Yield: |
4.97% |
6.63% |
| Dividend Yield: |
0.00% |
0.00% |
| Market Capitalization |
|
| Market Capitalization: |
65.24 bill. SEK |
48.94 bill. SEK |
| Free Float Market Cap.: |
27.89 bill. SEK |
20.92 bill. SEK |
| Market Cap. / Employee: |
43.23 mill. SEK |
32.43 mill. SEK |
| Shares Outstanding: |
303.82 mill. |
|
Profitability
| Gross Profit Margin: |
78.87% |
| EBIT Margin: |
31.57% |
| Net Profit Margin: |
21.26% |
| Return on Equity: |
16.06% |
| Return on Assets: |
6.72% |
Financial Strength
| Liquidity I / Cash Ratio: |
3.87% |
| Liquidity II / Quick Ratio: |
39.84% |
| Liquidity III / Current Ratio: |
78.22% |
| Debt / Equity Ratio: |
138.95% |
| Dynam. Debt / Equity Ratio: |
538.49% |
Efficiency
| Employees: |
1,509 |
| Personal Expenses / Employee: |
1,491,053.68 SEK |
| Revenues / Employee: |
10,113,320.08 SEK |
| Net Income / Employee: |
2,150,430.75 SEK |
| Total Assets / Employee: |
31,996,686.55 SEK |
| * Fiscal Year End: |
12/31/2020 |
| Accounting Standard: |
IFRS |